Where Scientists Meet Antibody Success
ProSci specializes in catalog antibody products and custom antibody services. For over 20 years, a combination of developing catalog antibodies, providing antibody services, and conducting antibody-related R&D makes ProSci unique in the antibody market in the US and worldwide.
ProSci's mission is to provide extensive expertise in developing valuable antibodies to support our partners in order to improve human health globally.
Catalog Antibody Products
ProSci began by developing and marketing antibodies against novel targets, including apoptosis molecules and HIV coreceptors. ProSci expanded its antibody product lines to signal transduction, cancer, neurology, and immuno-oncology. During its two decades, ProSci established efficient capabilities to develop diverse antibody lines, including affinity purified polyclonal antibodies, hybridoma lines, and recombinant antibodies. ProSci is establishing an extensive antibody validation program to provide specific and reproducible products to the antibody market.
Custom Antibody Services (CAS)
ProSci provides custom antibody development services, including polyclonal, monoclonal, and single domain, against a large diversity of antigens from proteins and peptides to small molecules and carbohydrates, idiotypes, and whole cells. ProSci continues to deliver antibodies for many difficult projects such as single amino acid mutation specific, peptide terminal specific, self-carbohydrates from N-glycans, GPCRs, etc. The combination of a highly experienced scientific team and an incredible customer care team facilitates delivers to a wide array of customers including academia, government, biotech, diagnostic, and pharmaceutical companies.
Antibody Focused R&D
ProSci led a multi-year R&D project to develop broadly neutralizing antibodies by targeting the viral glycan shield for an HIV vaccine. This study resulted in one patent, six peer reviewed publications, and multiple SBIR awards from NIH. This 15+ year study built a profound foundation for successfully developing various challenging custom antibodies. ProSci has established its own proprietary techniques to develop single domain antibodies (sdAbs) with picomolar affinity for diagnostic and therapeutic applications. A pipeline of sdAbs against immune checkpoint targets is currently in various stages of development.
ProSci’s antibody service capability, gained from its extensive antibody focused R&D, catalog antibody development and over 20,000 custom antibodies in its 20+ year history, assures confidence and ease to achieve customized antibody success.
- Your scientific partner providing guided antibody solutions
- Over 20 years experience in antibody focused R&D and custom antibody development
- Generating the desired immune response for your most challenging antigens